Biomarkers in Breast Cancer /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2006.
|
| Edición: | 1st ed. 2006. |
| Colección: | Cancer Drug Discovery and Development,
|
| Materias: |
Tabla de Contenidos:
- General Topics
- Guidelines for the Design of Clinical Studies for the Development and Validation of Therapeutically Relevant Biomarkers and Biomarker-Based Classification Systems
- Analytical Aspects of Biomarker Immunoassays in Cancer Research
- Tissue Microarrays
- Assays for Gene Expression and Post-Translational Protein Abnormalities
- Gene Expression Profiling with DNA Microarrays
- Assays for DNA Abnormalities
- Assays for Gene Amplification
- Tissue Predictive Biomakers
- Cell Kinetics
- Urokinase-Type Plasminogen Activator and PAI-1
- Predictive Value of c
- erb-B2 for Endocrine Therapy and Chemotherapy in Breast Cancer
- erb-B2 as a Therapeutic Target
- The Epidermal Growth Factor Receptor Pathway as a Selective Molecular-Targeted Treatment in Human Breast Cancer
- p53 as a Prognostic and Predictive Indicator
- Predictive Biomarkers in Body Fluids
- Occult Metastatic Cells in Breast Cancer Patients
- Circulating HER2/neu
- Circulating Vascular Endothelial Growth Factor
- Detection of Early Tumor Dissemination in Patients With Breast Cancer
- Future Directions
- New Technologies/New Markers/New Challenges.